A method for the purification of phospho(Tyr)calmodulin free of nonphosphorylated calmodulin.
Phosphocalmodulin has been shown to have a differential biological activity compared to nonphosphorylated calmodulin when assayed on a variety of calmodulin-dependent systems. However, the phosphocalmodulin preparations used so far in those experiments were not necessarily free of nonphosphorylated calmodulin. Therefore, the results obtained may not unquestionably show the real effect of pure phosphocalmodulin on the systems under study. To solve this problem, we describe here a method for the purification of phospho(Tyr)calmodulin free of nonphosphorylated calmodulin. The procedure consists of the following steps: (i) phosphorylation of calmodulin by a fraction enriched in epidermal growth factor receptor tyrosine kinase from rat liver isolated by calmodulin affinity chromatography, (ii) isolation of a calmodulin/phosphocalmodulin mixture by Ca(2+)-dependent chromatography in phenyl-Sepharose, (iii) purification of phospho(Tyr)calmodulin using an anti-phosphotyrosine antibody immobilized in agarose upon elution with phenyl phosphate, and (iv) removal of phenyl phosphate from the phospho(Tyr)calmodulin preparation by filtration chromatography in a Bio-Gel P-2 column. The obtained phospho(Tyr)calmodulin preparation was highly pure and essentially free of nonphosphorylated calmodulin because of the use of anti-phosphotyrosine affinity chromatography. We demonstrate that this ultrapure phospho(Tyr)calmodulin preparation is totally incapable of activating the calmodulin-dependent cyclic nucleotide phosphodiesterase. In contrast, when a nonpurified phospho(Tyr)calmodulin preparation was used a partial activation of this enzyme was observed.
Palomo-Jiménez
P I
PI
Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier 4, Madrid, E-28029, Spain.
Hernández-Hernando
S
S
García-Nieto
R M
RM
Villalobo
A
A
D000818:Animals; D002147:Calmodulin / Q000031:analogs & derivatives* / Q000097:blood / Q000302:isolation & purification*; D002462:Cell Membrane / Q000737:chemistry; D002623:Chemistry Techniques, Analytical / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D004533:Egtazic Acid / Q000494:pharmacology; D066246:ErbB Receptors / Q000302:isolation & purification; D015151:Immunoblotting; D008099:Liver / Q000737:chemistry; D019606:Phosphoamino Acids / Q000378:metabolism; D010750:Phosphoproteins / Q000302:isolation & purification*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D017207:Rats, Sprague-Dawley
D002147:Calmodulin; D019606:Phosphoamino Acids; D010750:Phosphoproteins; D004533:Egtazic Acid; D066246:ErbB Receptors; D010727:Phosphoric Diester Hydrolases